Blog From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.By James Lu, MD, PhD, CEO and Co-Founder of Helix
Press ReleasesHelix Announces Multi-Year Agreement with Alnylam to Drive Precision Medicine DevelopmentMarch 5, 2026
Press ReleasesHelix Partners with Mawi DNA Technologies to Expand Access to Non-Invasive Genomic Sample CollectionFebruary 10, 2026
Press ReleasesHelix Announces Multi-Year Strategic Collaboration with GSK to Drive Precision Medicine DevelopmentJanuary 7, 2026
VideosPartner Perspectives with Nebraska MedicineGenetic Insights Project helps Nebraskans take charge of their health
1Published ResearchPopulation Genomic Screening Improves Lipid Management in Familial HypercholesterolemiaNovember 6, 2025
2Published ResearchPopulation Genomic Screening and Improved Lipid Management in Patients With Familial HypercholesterolemiaNovember 5, 2025
3Published ResearchFrom Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World EvidenceAugust 15, 2025
4Published ResearchNovel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse CohortJuly 30, 2025
5Published ResearchChatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering ProjectJune 10, 2025
VideosApr 1, 2022White House Summit on Strengthening the Nation’s Early Warning System for Health Threats
Press ReleasesMar 23, 2022Thermo Fisher Scientific, Helix and Rosalind to Support National Program to Accelerate SARS-CoV-2 Variant Identification
ResearchMar 22, 2022Applying Implementation Science to Support the Success of a Precision Health Initiative in a Learning Health SystemACMG 2022
ResearchMar 22, 2022Integration of personalized medicine into primary care clinics: A path to make large scale population genomics studies successfulACMG 2022
Blog From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.By James Lu, MD, PhD, CEO and Co-Founder of Helix
Press ReleasesHelix Announces Multi-Year Agreement with Alnylam to Drive Precision Medicine DevelopmentMarch 5, 2026
Press ReleasesHelix Partners with Mawi DNA Technologies to Expand Access to Non-Invasive Genomic Sample CollectionFebruary 10, 2026
Press ReleasesHelix Announces Multi-Year Strategic Collaboration with GSK to Drive Precision Medicine DevelopmentJanuary 7, 2026
VideosPartner Perspectives with Nebraska MedicineGenetic Insights Project helps Nebraskans take charge of their health
1Published ResearchPopulation Genomic Screening Improves Lipid Management in Familial HypercholesterolemiaNovember 6, 2025
2Published ResearchPopulation Genomic Screening and Improved Lipid Management in Patients With Familial HypercholesterolemiaNovember 5, 2025
3Published ResearchFrom Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World EvidenceAugust 15, 2025
4Published ResearchNovel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse CohortJuly 30, 2025
5Published ResearchChatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering ProjectJune 10, 2025